Singh Sheetu, Singh Nishtha
Department of Chest and Tuberculosis, SMS Medical College, Jaipur, Rajasthan, India.
Consultant, Department of Pulmonary Medicine, Asthma Bhawan, Jaipur, Rajasthan, India.
Lung India. 2017 Jan-Feb;34(1):13-18. doi: 10.4103/0970-2113.197093.
Respiratory diseases are a common problem in our country and these are associated with significant morbidity and mortality.
The aim of the paper was to analyze the pattern of diagnostic tests used and treatment prescribed for common respiratory diseases.
A total of 1028 pulmonologists, either member of Indian Chest Society or delegate attending the National Conference of Pulmonary Diseases (NAPCON) 2015, participated in the online survey.
The survey included questions pertinent to common respiratory diseases such as pulmonary tuberculosis (PTB), bronchial asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and pneumonia.
Investigation used for severity assessment and diagnosis of PTB, was sputum for acid-fast bacilli (83.5%), for IPF was high-resolution computed tomography chest (85.6%), for severe pneumonia was arterial blood gas analysis (69.3%), for asthma was spirometery and peak flow (96.8%) and for COPDs was spirometry (87.2%). The most popular choice of treatment for PTB was directly observed treatment short course (55.7%), for bronchial asthma, it was long-acting beta agonist with inhaled corticosteroids (LABA + ICSs) (41.1%), for COPD, it was LABA, ICS, and long-acting muscarinic antagonist (LABA + ICS + long-acting muscarinic antagonist) (32.4%) and for IPF, it was pirfenidone and N acetyl cysteine (38.3%). About 67.5% of doctors preferred hospitalization for patients with severe pneumonia. About 84.5% pulmonologists ordered diagnostic tests and 55.5% prescribed treatment as per current guidelines.
The majority of doctors (70.1%) in our survey followed recommended guidelines for respiratory disease diagnosis and treatment. However, there is a need for upgradation of treatment strategies currently used by doctors.
呼吸系统疾病在我国是一个常见问题,且与较高的发病率和死亡率相关。
本文旨在分析常见呼吸系统疾病的诊断检查模式及所采用的治疗方法。
共有1028名肺科医生参与了在线调查,他们要么是印度胸科学会的成员,要么是参加2015年全国肺部疾病会议(NAPCON)的代表。
该调查涵盖了与常见呼吸系统疾病相关的问题,如肺结核(PTB)、支气管哮喘、慢性阻塞性肺疾病(COPD)、特发性肺纤维化(IPF)和肺炎。
用于肺结核严重程度评估和诊断的检查是痰涂片找抗酸杆菌(83.5%),用于特发性肺纤维化的是胸部高分辨率计算机断层扫描(85.6%),用于重症肺炎的是动脉血气分析(69.3%),用于哮喘的是肺功能测定和呼气峰流速(96.8%),用于慢性阻塞性肺疾病的是肺功能测定(87.2%)。肺结核最常用的治疗方法是直接观察短程治疗(55.7%),支气管哮喘是长效β受体激动剂联合吸入性糖皮质激素(LABA + ICSs)(41.1%),慢性阻塞性肺疾病是长效β受体激动剂、吸入性糖皮质激素和长效毒蕈碱拮抗剂(LABA + ICS +长效毒蕈碱拮抗剂)(32.4%),特发性肺纤维化是吡非尼酮和N - 乙酰半胱氨酸(38.3%)。约67.5%的医生倾向于让重症肺炎患者住院治疗。约84.5%的肺科医生按照现行指南进行诊断检查,55.5%的医生按照现行指南进行治疗。
在我们的调查中,大多数医生(70.1%)遵循了推荐的呼吸系统疾病诊断和治疗指南。然而,医生目前使用的治疗策略仍有改进的必要。